Pharmaceutical News

RSS

NICE issues second draft guidance on PIXUVRI for treatment of aggressive B-cell NHL

Cell Therapeutics, Inc. today announced that the National Institute for Health and Care Excellence, a non-departmental public body of the Department of Health in the United Kingdom, issued second draft guidance on PIXUVRI (pixantrone) as a monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma.

15 Oct 2013

Study: Non-hallucinogenic components of cannabis may act as effective anti-cancer agents

The anti-cancer properties of tetrahydrocannabinol (THC), the primary hallucinogenic component of cannabis, has been recognised for many years, but research into similar cannabis-derived compounds, known as cannabinoids, has been limited.

15 Oct 2013

High doses of ADHD drugs may be effective for people with amphetamine dependency

People with ADHD and dependency rarely respond as they should to ADHD drugs. A randomised study from Karolinska Institutet in Sweden now shows that it is possible to obtain the desired efficacy by administering the drug in higher doses.

15 Oct 2013

Teva gets FDA approval for generic version of TOBI in US

Teva Pharmaceutical Industries Ltd. announces today that the U.S. Food and Drug Administration has granted approval of the generic equivalent to TOBI (Tobramycin Inhalation Solution USP) in the United States.

15 Oct 2013

FDA approves OTREXUP injection for adults with RA, children with active pJIA

Antares Pharma, Inc. today announced the approval of OTREXUP (methotrexate) injection by the U.S. Food and Drug Administration. OTREXUP is the first FDA approved subcutaneous methotrexate for once weekly self-administration with an easy-to-use, single dose, disposable auto injector.

14 Oct 2013

Statins may increase risk of cataracts among individuals above 30 years old

According to the Centers for Disease Control and Prevention, cataracts are the number one cause of vision loss in the United States. Nearly 22 million Americans age 40 and over have cataracts, while more than half of individuals age 80 and over suffer from this condition. In a recent study released in JAMA Ophthalmology, it was confirmed that statins, which are typically prescribed to reduce cholesterol and also prevent heart disease, may cause an increased risk for cataracts among individuals ages 30 through 85.

14 Oct 2013

Blood test can help predict which bipolar patients will benefit from Ketamine

Researchers have discovered how to determine which bipolar patients will benefit from Ketamine, a treatment commonly used for depression and pain relief, according to a study presented at the ANESTHESIOLOGY 2013 annual meeting.

14 Oct 2013

BioInvent extends license agreement with Bayer to develop antibodies

BioInvent International AB today announces that it has signed an extension to its 2008 license agreement with Bayer Pharma AG for the development of antibodies from BioInvent's n-CoDeR libraries.

14 Oct 2013

Pregabalin drug can help reduce incidence of chronic pain following cardiac surgery

The incidence of chronic pain following cardiac surgery can be reduced in patients when the drug pregabalin is used before surgery and for 14 days post-surgery, according to a study presented at the ANESTHESIOLOGY 2013 annual meeting.

14 Oct 2013

Multi-drug therapy can benefit patients at higher risk for post-operative nausea and vomiting

Ninety-seven percent of bariatric surgery patients avoided post-operative nausea and vomiting with the addition of a second drug to the standard treatment given during surgery, according to a study presented at the ANESTHESIOLOGY 2013 annual meeting.

14 Oct 2013

ASA launches Opioid Overdose Resuscitation card to help people who abuse prescription drugs

In response to the prescription drug abuse epidemic in the United States, the American Society of Anesthesiologists is collaborating with the White House Office of National Drug Control Policy to respond to the problem, educate the public and advance programs to help those who misuse and abuse prescription drugs.

14 Oct 2013

IV lidocaine infusion provides significant pain relief to fibromyalgia patients

Patients with fibromyalgia resistant to more routine therapies have a new pain relief treatment available, according to a study presented at the ANESTHESIOLOGY 2013 annual meeting.

14 Oct 2013

Researchers discover new approach to tackle global threat of antibiotic drug resistance

Researchers at McMaster University are addressing the crisis in drug resistance with a novel approach to find new antibiotics.

13 Oct 2013

PARP inhibitor drugs and chemotherapy can help women with ovarian cancer live longer

Conventional chemotherapy could further extend life in some women with ovarian cancer when used in tandem with a new type of targeted treatment, a new international study shows.

13 Oct 2013

Use of IV acetaminophen with narcotics reduces pain in children with tonsillectomies

Using intravenous acetaminophen with narcotics provides more effective pain relief to children having tonsillectomies, according to a study presented at the ANESTHESIOLOGY 2013 annual meeting.

13 Oct 2013

New study illustrates impact of oral nutrition supplement use in pediatric hospitalized patients

A new study has found that the use of oral nutritional supplements provided to pediatric patients during hospitalization was associated with a decrease in length of stay of 14.8 percent and a decrease in hospital stay costs of $1,768 per patient.

12 Oct 2013

Researchers discover how Fra-1 protein protects the liver from drug-induced liver damage

Drug abuse and alcohol are some of the most frequent causes of liver damage, particularly in developed countries. Such kind of liver damage can cause irreversible liver failure and even cancer. Researchers from the Spanish National Cancer Research Centre have discovered an important new protective role of the Fra-1 protein, which neutralizes the damage caused by agents, such as the analgesic drug acetaminophen (Paracetamol).

12 Oct 2013

NPC recalls Albuterol Sulfate Inhalation Solution

Nephron Pharmaceuticals Corporation has initiated a voluntary recall, at the retail level, as a precautionary measure, due to results from our internal monitoring processes.

12 Oct 2013

Sanofi's Nasacort Allergy 24HR nasal spray receives FDA approval for over-the-counter use

Sanofi announced today that the U.S. Food and Drug Administration approved Nasacort Allergy 24HR nasal spray as an over-the-counter treatment for seasonal and year-round nasal allergies in adults and children 2 years of age and older.

12 Oct 2013

Auxilium Pharmaceuticals gets exclusive right to market VIVUS's STENDRA in the US and Canada

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, announced today the signing of an agreement with VIVUS, Inc. providing Auxilium with the exclusive right to market VIVUS's product, STENDRA (avanafil), in the United States and Canada.

11 Oct 2013

Pharmaceutical News

NICE issues second draft guidance on PIXUVRI for treatment of aggressive B-cell NHL

Study: Non-hallucinogenic components of cannabis may act as effective anti-cancer agents

High doses of ADHD drugs may be effective for people with amphetamine dependency

Teva gets FDA approval for generic version of TOBI in US

FDA approves OTREXUP injection for adults with RA, children with active pJIA

Statins may increase risk of cataracts among individuals above 30 years old

Blood test can help predict which bipolar patients will benefit from Ketamine

BioInvent extends license agreement with Bayer to develop antibodies

Pregabalin drug can help reduce incidence of chronic pain following cardiac surgery

Multi-drug therapy can benefit patients at higher risk for post-operative nausea and vomiting

ASA launches Opioid Overdose Resuscitation card to help people who abuse prescription drugs

IV lidocaine infusion provides significant pain relief to fibromyalgia patients

Researchers discover new approach to tackle global threat of antibiotic drug resistance

PARP inhibitor drugs and chemotherapy can help women with ovarian cancer live longer

Use of IV acetaminophen with narcotics reduces pain in children with tonsillectomies

New study illustrates impact of oral nutrition supplement use in pediatric hospitalized patients

Researchers discover how Fra-1 protein protects the liver from drug-induced liver damage

NPC recalls Albuterol Sulfate Inhalation Solution

Sanofi's Nasacort Allergy 24HR nasal spray receives FDA approval for over-the-counter use

Auxilium Pharmaceuticals gets exclusive right to market VIVUS's STENDRA in the US and Canada

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News